MADD Antikörper (AA 1100-1150)
-
- Target Alle MADD Antikörper anzeigen
- MADD (MAP-Kinase Activating Death Domain (MADD))
-
Bindungsspezifität
- AA 1100-1150
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MADD Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Verwendungszweck
- Rabbit anti-MADD Antibody, Affinity Purified
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 1100 and 1150
- Isotyp
- IgG
- Top Product
- Discover our top product MADD Primärantikörper
-
-
- Applikationshinweise
-
IP: 2 - 5 μg/mg lysate
WB: 1:2,000 - 1:10,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 200 μg/mL
- Buffer
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- MADD (MAP-Kinase Activating Death Domain (MADD))
- Andere Bezeichnung
- MADD (MADD Produkte)
- Hintergrund
- Background: MAP kinase-activating death domain protein (MADD) is a death domain containing protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activate protein kinase (MAPK) and transduce apoptotic signals. MADD is a multi-pass membrane protein that exists as multiple alternatively spliced forms.
- Gen-ID
- 8567
- NCBI Accession
- NP_003673
- UniProt
- Q8WXG6
- Pathways
- Caspase Kaskade in der Apoptose
-